UnitedHealth Group (NYSE:UNH) Shares Down 5.5% - Should You Sell?

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • UnitedHealth shares fell 5.5% to $330.58, with trading volume 173% above average.
  • Regulatory and legal concerns are weighing on sentiment: lawmakers renewed calls to break up large healthcare companies, and a law firm announced a shareholder investigation into the company’s disclosure of audit exposure. The investigation is pending and is not a finding of wrongdoing.
  • Despite the sell-off, UnitedHealth beat quarterly earnings and revenue estimates; analysts’ consensus rating is “Moderate Buy,” with an average price target of $463.93. The company also announced a quarterly dividend of $2.32 per share.
  • Five stocks we like better than UnitedHealth Group.

Shares of UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) dropped 5.5% during trading on Thursday. The stock traded as low as $324.67 and last traded at $330.58. 19,789,163 shares were traded during trading, an increase of 173% from the average session volume of 7,251,102 shares. The stock had previously closed at $349.91.

UnitedHealth Group News Roundup

These are some of the UNH news items that stood out recently:

Analyst Upgrades and Downgrades

UNH has been the topic of several research reports. Erste Group Bank cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, August 27th. Zacks Research lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 14th. Weiss Ratings upgraded UnitedHealth Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, October 8th. Piper Sandler increased their price objective on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an "overweight" rating in a research report on Wednesday, October 14th. Finally, UBS Group reaffirmed an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $463.93.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Down 5.5%

The stock has a market cap of $296.21 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 1.41 and a beta of 0.51. The business's 50 day moving average is $390.56 and its 200-day moving average is $367.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group's dividend payout ratio (DPR) is 53.00%.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.19% of the company's stock.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Fi3 FINANCIAL ADVISORS LLC acquired a new position in UnitedHealth Group during the third quarter worth $769,000. Heartland Bank & Trust Co lifted its position in UnitedHealth Group by 4.2% in the third quarter. Heartland Bank & Trust Co now owns 3,749 shares of the healthcare conglomerate's stock valued at $1,376,000 after acquiring an additional 152 shares during the last quarter. Kensington Investment Counsel LLC boosted its stake in UnitedHealth Group by 1.8% during the 3rd quarter. Kensington Investment Counsel LLC now owns 8,162 shares of the healthcare conglomerate's stock worth $2,996,000 after purchasing an additional 143 shares during the period. Robinhood Markets Inc. purchased a new position in UnitedHealth Group in the 3rd quarter valued at $114,000. Finally, Innovator Capital Management LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $18,310,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines